Skip to content

Absci Corporation ABSI Increase (decrease) in contract liabilities and current deferred income

Increase (decrease) in contract liabilities and current deferred income at other companies

Zymeworks logo
ZymeworksZYME
-$340K+83.8%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-$749K

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's increase (decrease) in contract liabilities and current deferred income?
Absci Corporation (ABSI) reported increase (decrease) in contract liabilities and current deferred income of -$83K in Q1 2026.
How has Absci Corporation's increase (decrease) in contract liabilities and current deferred income changed year-over-year?
Absci Corporation's increase (decrease) in contract liabilities and current deferred income decreased by 315.0% year-over-year, from -$20K to -$83K.
What is the long-term trend for Absci Corporation's increase (decrease) in contract liabilities and current deferred income?
Over 2 years (2022 to 2024), Absci Corporation's increase (decrease) in contract liabilities and current deferred income has grown at a 82.6% compound annual growth rate (CAGR), from -$907K to -$3.02M.